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We conducted a cohort study of alcohol consumption and total cancer incidence and mortality in 73281 subjects (35007 men and
38274 women) aged 40–59 years old at baseline over a 10-year follow-up period. During 1990–2001, a total of 3403 cases of
newly diagnosed cancer and 1208 cancer deaths were identified. In men, the lowest risk of developing cancer was observed among
occasional drinkers, and a linear positive association with increased ethanol intake was noted (hazard ratio 1.18 for 1–149g per
week, 1.17 for 150–299g per week, 1.43 for 300–449g per week, 1.61 for X450g per week, P for trend o0.001). The positive
relation was similar for cancer incidence and mortality, but was more striking among current smokers and alcohol-related cancers.
Relatively few women were regular drinkers. Our results suggest that increased ethanol intake linearly elevates the risk of cancer, and
that nearly 13% of cancers among males in this study were due to heavy drinking (X300g per week of ethanol), to which smoking
substantially contributed. The simultaneous reduction of smoking is therefore important for reducing the effect of alcohol on cancer
risk.
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In Japan, both alcohol consumption and the proportion of heavy
drinkers have been increasing for decades (The Editorial Board of
the Cancer Statistics in Japan, 2003), and alcohol drinking has been
recognised as an important and preventable public health problem.
A quantitative estimation of the effects of alcohol drinking in a
target population, with regard to not only specific cancers but also
total cancers, is important in formulating public health policies.
However, evidence of the association between alcohol and total
cancer risk mainly concerns Western populations and cancer
mortality (Blackwelder et al, 1980; Blot, 1992; Doll et al, 1994;
Fuchs et al, 1995; Camargo et al, 1997; Renaud et al, 1998;
Berberian et al, 1994; Gaziano et al, 2000; Bagnardi et al, 2001;
Theobald et al, 2001). Little has been reported for Japanese or
other ethnic groups (Kono et al, 1986; Yuan et al, 1997, Tsugane
et al, 1999).
As the epidemiological background, types of beverage regularly
consumed and genetic polymorphisms for alcohol-related enzymes
in these ethnic groups differ from those in Western populations,
we have conducted a cohort analysis of the question using a large-
scale population-based prospective study with a 10-year follow-up
period.
METHODS
Study population and baseline survey
The Japan Public Health Center-based prospective Study (JPHC
Study) was launched in 1990 for Cohort I and in 1993 for Cohort II.
Cohort I covered five prefectural public health center (PHC) areas
and Cohort II covered six PHC areas. The details of the study
design have been described elsewhere (Tsugane and Sobue, 2001).
The study protocol was approved by the institutional review board
of the National Cancer Center, Japan. In the present analysis, two
PHC areas were excluded since different definitions of the study
population had been applied.
The study population was defined as all registered Japanese
inhabitants in the nine PHC areas aged 40–59 years at the start of
each baseline survey. Initially, 96616 subjects were identified but
after excluding 178 subjects with non-Japanese nationality
(n¼45), late reports of emigration occurring before the start of
the follow-up period (n¼131), and incorrect birth date (n¼2), a
population-based cohort of 96438 subjects (48240 men and 48198
women) was established.
A baseline self-administered questionnaire survey on various
lifestyle factors was conducted in 1990 for Cohort I and in 1993–
1994 for Cohort II, with a response rate of 81%. After excluding
subjects with a self-reported serious illness (cancer, cerebrovas-
cular disease, myocardial infarction, or chronic liver disease) and
those without details of alcohol status, 73281 subjects (35007 men
and 38274 women) remained for analysis.
Information on alcohol intake was obtained in terms of
frequency and the amount using validated questions (Otani et al,
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y2003; Tsubono et al, 2003). The average frequency was reported in
six categories for cohort I: o1 day per month, 1–3 days per
month, 1–2 days per week, 3–4 days per week, 5–6 days per week,
and everyday. Subjects consuming alcoholic beverages at least
once a week were also asked about the types of drinks consumed
and the average consumption. Subjects in cohort II were also asked
about their drinking status, never-, ex-, or current drinkers. Ex-
and current drinkers provided information on the average
frequency, the types of drinks consumed and average daily
consumption. The average frequency of consumption was divided
into the following categories, to each of which a score was
assigned: 1.5 for 1–2 days per week, 3.5 for 3–4 days per week, and
6 for 5–6 days per week and everyday in the cohort I
questionnaire, and 1.5 for 1–2 days per week, 3.5 for 3–4 days
per week, and 6 for almost everyday in the cohort II questionnaire.
The amount of ethanol by type of beverage was calculated as
follows: 180ml of sake (rice wine) was regarded as 23g of ethanol,
180ml of shochu or awamori (white spirits) as 36g, 633ml of beer
as 23g, 30ml of whiskey or brandy as 10g, and 60ml wine as 6g.
Finally, the weekly ethanol intake was estimated by multiplying the
amount by the score. In the present analysis, alcohol drinking was
classified into six categories: nondrinkers (o1 day per month),
occasional drinkers (1–3 days per week), and four categories of
regular drinkers (1–149, 150–299, 300–449, and X450g per
week).
Follow-up and analysis
Subjects were followed from the baseline survey until December
31, 2001. Residence status, including survival, was confirmed
annually through the residential registry kept in each municipality
of the areas where the study subjects resided. Among the study
subjects, 6.5% moved away and 0.06% were lost to follow-up
during the study period. Information on the cause of each death
was supplemented by checking against death certificate files with
permission, and the cause of death was defined according to the
International Classification of Disease, 10th Version (ICD-10)
(WHO, 1990).
Cancers were identified by active patient notification from the
local major hospitals in the study area and approved data linkage
with the population-based cancer registries. Death certificates were
used as a supplementary information source. Cases were coded
using the International Classification of Diseases for Oncology,
Third Edition (ICD-O-3) (WHO, 2000). In 2.2% of cancer cases,
information was available only from death certificates (DCO). The
earliest date of diagnosis was used in cases with multiple primary
cancers at different times.
Person-years were accrued from baseline survey until the
following end points: for cancer incidence – the date of occurrence
of cancer, the date of emigration from the study area, the date of
death, or the end of the study period, whichever came first; for
total cancer deaths, the date of emigration from the study area, the
date of death, or the end of the study period, whichever came first.
Persons who were lost to follow-up were censored at the last
confirmed date of presence in the study area.
The study outcomes were defined as newly occurring cancers of
any site and all cancer deaths during the study period. Hazard
ratios (HR) and their 95% confidence intervals (95% CI) were used
to describe the relative risk cancer deaths associated with the
alcohol categories at baseline (nondrinkers, occasional drinkers,
1–149g of ethanol per week, 150–299, 300–449, and X450g per
week), with ‘occasional drinkers’ representing the reference
category. In men, stratified analyses were further conducted to
evaluate whether alcohol effects and cancer risk varied with
smoking status. Interaction terms were generated by multiplying
the ordinal smoking categories by ordinal alcohol drinking
categories. The HRs were further estimated separately for
alcohol-related cancers, namely cancer of the oral cavity, pharynx,
larynx, oesophagus, and liver (IARC, 1988; WHO, 2003) (ICD-0-3:
C00-C10, C12-C15, C22, C32), and for cancers not considered to be
alcohol-related. The Cox proportional hazards model was used to
control for such potential confounding factors as age at baseline
Table 1 Baseline characteristics of the study subjects according to alcohol drinking category
Alcohol drinking category
Weekly ethanol intake (g per week)
Total Nondrinkers Occasional drinkers 1–149 150–299 300–449 X450
Men (n¼35007)
Number of subjects 35007 7009 3555 7853 7039 4899 4652
Proportion (%) 20.0 10.2 22.4 20.1 14.0 13.3
Age (years) 7s.d. 49.175.9 49.876.0 48.675.9 48.776.0 49.075.9 49.475.8 49.175.9
Smoking status (%)
Never 24.7 29.5 33.0 30.2 21.3 16.9 15.5
Former 21.1 19.8 19.0 22.7 21.9 21.6 20.1
Current 54.2 50.7 48.0 47.1 56.8 61.5 64.4
Green vegetable intake (%)
Almost everyday 23.5 23.8 24.1 22.4 23.2 24.4 23.6
Leisure-time physical activity (%)
X 1–2 times per week 18.0 15.2 18.7 21.0 18.5 17.9 15.6
Women (n¼38274)
Number of subjects 38274 29356 4329 3584 593 191 221
Proportion (%) 76.7 11.3 9.4 1.5 0.5 0.6
Age (years) 7s.d. 49.475.9 49.875.9 47.875.7 48.075.6 47.975.7 47.275.4 47.375.5
Smoking status (%)
Never 92.4 94.8 90.4 85.6 60.6 52.9 49.3
Former 1.4 1.0 2.1 2.4 6.3 6.8 3.6
Current 6.2 4.2 7.5 12.0 33.2 40.3 47.1
Green vegetable intake (%)
Almost everyday 31.1 31.6 28.2 31.1 27.9 22.2 27.9
Leisure-time physical activity (%)
X1–2 times per week 15.8 15.0 18.1 19.3 16.9 14.7 13.2
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y(continuous), study area (nine PHC areas), smoking status (pack-
years (0, 1–19, 20–29, 30–39, X40)), green vegetable intake
(p3–4 times per week, everyday), and leisure-time physical
activity (p1–3 times per month, X1–2 times per week). These
variables are either known or suspected risk factors for cancer or
had been found to be associated with cancer risk in previous
studies (Tsugane et al, 1999; Hara et al, 2002).
To express the impact of alcohol drinking on the risk of overall
cancer, the population-attributable fraction (PAF) (%) was
estimated as pd (HR 1/HR), where pd is the proportion of
cases exposed to the risk factors. This formula is considered more
valid than the popular formula Pe (RR 1)/(Pe (RR 1)þ1),
where Pe is the proportion of the source population exposed to the
risk factor, when a confounding variable exists (Rockhill et al,
1998). Confidence intervals (95%) for the adjusted PAF were
estimated using the formula of Greenland (1999). Stata version 8
special edition software (Stata Corporation, 2003) was used to
perform the statistical analyses.
RESULTS
During the 721302.5 person-years of follow-up (average: 9.8 years)
for the 73281 subjects (35007 men and 38274 women), a total of
3403 newly diagnosed cancers (1904 men and 1499 women) and
1208 cancer deaths (758 men and 450 women) were included in the
analyses. With regard to cancer incidence, gastric cancer was the
commonest cancer in men (n¼533, 28.0%), followed by colon
(n¼281) and lung cancers (n¼230); in women, breast cancer was
commonest (n¼314, 20.9%), followed by gastric cancer (n¼203),
and colon cancers (n¼170). For mortality, lung cancer was the
commonest cause of cancer death in men (n¼167, 22.0%),
followed by gastric (n¼148) and liver cancer (n¼74); in women,
gastric cancer was the commonest cause of cancer death (n¼58,
12.9%), followed by lung (n¼56), and breast cancer (n¼40).
At baseline, 70% of men were regular drinkers and 48%
consumed alcohol 3–4 times per week or more; in women, 77%
were nondrinkers and 12% regular drinkers. The average
frequency of alcohol consumption among regular drinkers was
5.2 days per week in men and 3.6 days per week in women. Both in
men and women (Table 1), the proportion of current smokers was
increased in the higher ethanol intake groups, in which leisure-
time physical activities were less frequent. However, no consistent
trend in green vegetable intake was observed across the alcohol
categories.
The adjusted cancer HRs by alcohol category are presented in
Table 2, together with the ratios for cancer mortality. In men, the
lowest risk was observed in occasional drinkers, compared to
Table 2 Hazard ratios (HR)
a and 95% confidence interval (95% CI) of cancer incidence and deaths according to alcohol-drinking status
Weekly ethanol intake (g per week)
Nondrinkers
Occasional
drinkers 1–149 150–299 300–449 X450 P for trend
Men (n¼35007)
Cancer incidence Person-years 68161.0 35151.9 74007.4 67934.7 48173.5 46194.9
Total (n¼1904)
No. of cases 360 138 353 359 339 355
HR (95% CI) 1.10 (0.90–1.34) 1.00 (reference) 1.18 (0.96–1.44) 1.17 (0.96–1.44) 1.43 (1.17–1.75) 1.61 (1.32–1.97) o0.001
PAF% (95% CI) 5.4 (1.4–9.1) 7.1 (2.9–11.0)
Excluding first 5 years (n¼1172)
No. of cases 214 81 217 234 206 220
HR (95% CI) 1.11 (0.86–1.44) 1.00 (reference) 1.25 (0.97–1.62) 1.29 (0.99–1.67) 1.44 (1.10–1.87) 1.64 (1.26–2.12) 0.002
PAF% (95% CI) 5.4 (0.3–10.2) 7.3 (1.9–12.4)
Cancer deaths Person-years 69175.7 35547.7 75042.2 69039.4 49194.1 47259.3
Total (n¼758)
No. of cases 161 59 138 119 133 148
HR (95% CI) 1.10 (0.81–1.49) 1.00 (reference) 1.06 0.77–1.44) 0.92 (0.67–1.26) 1.33 (0.97–1.83) 1.58 (1.16–2.15) o0.001
PAF% (95% CI) 4.4 ( 1.7–10.1) 7.1 (0.4–13.4)
Excluding first 5 years (n¼533)
No. of cases 107 35 106 82 96 107
HR (95% CI) 1.25 (0.85–1.85) 1.00 (reference) 1.39 (0.94–2.06) 1.08 (0.72–1.62) 1.62 (1.09–2.42) 1.90 (1.28–2.81) 0.009
PAF% (95% CI) 6.9 ( 1.1–14.3) 9.5 (0.6–17.6)
Women (n¼38274)
Cancer incidence Person-years 293866.0 43116.9 34966.7 5757.5 1803.8 2168.2
Total (n¼1499)
No. of cases 1170 178 118 20 6 7
HR (95% CI) 0.94 (0.80–1.11) 1.00 (reference) 0.80 (0.63–1.01) 0.68 (0.42–1.11) 0.73 (0.32–1.66) 0.68 (0.32–1.46) 0.659
Excluding first 5 years (n¼908)
No. of cases 707 115 68 12 3 3
HR (95% CI) 0.88 (0.72–1.08) 1.00 (reference) 0.70 (0.51–0.95) 0.59 (0.31–1.13) 0.59 (0.19–1.88) 0.47 (0.15–1.49) 0.351
Cancer deaths Person-years 298259.9 43775.0 35434.0 5827.6 1821.6 2187.6
Total (n¼450)
No. of cases 368 43 28 6 3 2
HR (95% CI) 1.08 (0.79–1.49) 1.00 (reference) 0.79 (0.49–1.27) 0.54 (0.19–1.52) 1.27 (0.39–4.15) 0.68 (0.16–2.86) 0.896
Excluding first 5 years (n¼325)
No. of cases 273 31 17 3 1 0
HR (95% CI) 1.14 (0.78–1.66) 1.00 (reference) 0.69 (0.38–1.25) 0.20 (0.03–1.51) 0.69 (0.09–5.09) — 0.289
aAdjusted for age at baseline (continuous), study area (9 PHC area), pack-years of smoking (0, 1–19, 20–29, 30–39, X40), green vegetable intake (p3–4 times per week,
almost everyday), and leisure-time physical activity (p1–3 times per month, X1–2 times per week).
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ywhom a significant increase in risks of cancer occurrence
was observed as ethanol intake increased among regular drinkers
(1–149g per week: HR¼1.18, 150–299g per week: HR¼1.17,
300–449g per week: HR¼1.43, X450g per week: HR¼1.61, P for
trend o0.001). This trend did not change when cases where the
cancers occurred within the first five years of the study were
excluded. For total cancer mortality, a similar trend was observed.
Among males, 12.5% of the cancers in the study period were
attributable to heavy drinking (X300g of ethanol per week): 5.4%
for the consumption of 300–449g of ethanol per week and 7.1%
for the consumption of X450 g per week. Similar results were
obtained for cancer mortality. Unlike men, cancer risk was the
Table 3 Hazard ratios (HR)
a and 95% confidence interval (95% CI) of cancer incidence and deaths attributed to alcohol-related cancers and nonalcohol-
related cancers
b according to the alcohol drinking status in men (n¼35007)
Weekly ethanol intake (g per week)
Nondrinkers
Occasional







No. of cases 78 42 75 54 37 30
HR (95% CI) 0.90 (0.62–1.31) 1.00 (reference) 0.87 (0.60–1.28) 0.86 (0.57–1.29) 1.03 (0.66–1.62) 1.02 (0.64–1.64) 0.370
Current smokers (n¼1163) 0.018
No. of cases 196 58 202 226 224 257
HR (95% CI) 1.39 (1.03–1.88) 1.00 (reference) 1.69 (1.25–2.28) 1.64 (1.22–2.20) 1.93 (1.43–2.60) 2.32 (1.72–3.11) o0.001
Alcohol–related cancers (n¼250)
No. of cases 29 8 38 49 52 74
HR (95% CI) 1.57 (0.72–3.45) 1.00 (reference) 2.28 (1.06–4.90) 2.95 (1.39–6.28) 4.03 (1.90–8.56) 6.16 (2.95–12.8) o0.001
Never smokers (n¼34)
No. of cases 7 2 8566
HR (95% CI) 1.88 (0.39–9.09) 1.00 (reference) 2.09 (0.44–9.95) 1.91 (0.37–9.95) 3.42 (0.65–17.9) 4.70 (0.93–23.7) 0.109
Current smokers (n¼163)
No. of cases 14 5 19 36 33 56
HR (95% CI) 1.12 (0.40–3.15) 1.00 (reference) 1.95 (0.73–5.24) 3.23 (1.26–8.28) 3.72 (1.44–9.62) 6.41 (2.55–16.1) o0.001
Nonalcohol-related cancers (n¼1654)
No. of cases 331 130 315 310 287 281
HR (95% CI) 1.07 (0.87–1.31) 1.00 (reference) 1.11 (0.90–1.36) 1.06 (0.86–1.31) 1.27 (1.03–1.57) 1.34 (1.11–1.66) 0.004
Never smokers (n¼282)
No. of cases 71 40 67 49 31 24
HR (95% CI) 0.85 (0.57–1.26) 1.00 (reference) 0.81 (0.55–1.20) 0.80 (0.53–1.23) 0.92 (0.57–1.48) 0.85 (0.51–1.42) 0.733
Current smokers (n¼1000)
No. of cases 182 53 183 190 191 201
HR (95% CI) 1.41 (1.03–1.93) 1.00 (reference) 1.66 (1.21–2.27) 1.48 (1.08–2.03) 1.76 (1.28–2.41) 1.94 (1.42–2.66) 0.039
Cancer deaths
Never–smokers (n¼124)
No. of cases 36 25 27 19 7 10
HR (95% CI) 0.67 (0.40–1.12) 1.00 (reference) 0.53 (0.31–0.92) 0.49 (0.27–0.91) 0.33 (0.14–0.78) 0.55 (0.26–1.16) 0.634
Current smokers (n¼484) o0.001
No. of cases 81 23 83 84 99 114
HR (95% CI) 1.43 (0.89–2.31) 1.00 (reference) 1.68 (1.04–2.69) 1.52 (0.94–2.44) 2.15 (1.35–3.44) 2.57 (1.62–4.09) o0.001
Alcohol–related cancers (n¼143)
No. of cases 19 5 25 28 31 35
HR (95% CI) 1.58 (0.59–4.25) 1.00 (reference) 2.26 (0.86–5.92) 2.55 (0.98–6.67) 3.86 (1.48–10.0) 4.89 (1.90–12.5) 0.003
Never smokers (n¼22)
No. of cases 7 2 4423
HR (95% CI) 1.76 (0.36–8.54) 1.00 (reference) 1.01 (0.18–5.59) 1.45 (0.26–8.04) 1.29 (0.18–9.37) 2.35 (0.38–14.4) 0.280
Current smokers (n¼89)
No. of cases 6 3 14 20 20 26
HR (95% CI) 0.81 (0.20–3.26) 1.00 (reference) 2.17 (0.62–7.57) 2.66 (0.78–9.07) 3.45 (1.01–11.8) 4.78 (1.43–15.9) 0.014
Nonalcohol-related cancers (n¼615)
No. of cases 142 54 113 91 102 113
HR (95% CI) 1.06 (0.77–1.45) 1.00 (reference) 0.94 (0.68–1.31) 0.76 (0.54–1.08) 1.09 (0.78–1.53) 1.27 (0.91–1.77) 0.010
Never smokers (n¼102)
No. of cases 29 23 23 15 5 7
HR (95% CI) 0.57 (0.33–1.00) 1.00 (reference) 0.49 (0.27–0.88) 0.41 (0.21–0.80) 0.26 (0.10–0.68) 0.41 (0.17–0.96) 0.287
Current smokers (n¼395)
No. of cases 75 20 69 64 79 88
HR (95% CI) 1.53 (0.92–2.54) 1.00 (reference) 1.60 (0.96–2.67) 1.34 (0.80–2.25) 1.96 (1.18–3.25) 2.25 (1.36–3.72) 0.008
aAdjusted for age at baseline (continuous), study area (9 PHC area), daily cigarette consumption (number of cigarettes, continuous, current smoker only), green vegetable intake
(p3–4 times per week, almost everyday), and leisure-time physical activity (p1–3 times per month, X1–2 times per week).
bAlcohol-related cancers consist of cancer of the
oral cavity, pharynx, oesophagus, liver, and larynx. Nonalcohol-related cancers consist of all other cancers not considered to be alcohol related.
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yhighest among occasional drinkers in women, but none of the risk
values reached statistical significance.
The HRs for cancer in men were estimated separately by
smoking status at baseline for each alcohol-drinking category
(Table 3). For cancer incidence, no risk fluctuation was observed
among never-smokers, whereas current smokers exhibited a
constantly elevated risk compared with occasional drinkers (1–
149g per week: HR¼1.69, 150–299g per week: HR¼1.64, 300–
449g per week: HR¼1.93, X450g per week: HR¼2.32, P for trend
o0.001). Similar trends were observed for cancer mortality, with a
somewhat decreased risk tendency among never-smokers. A
statistically significant interaction between alcohol and smoking
status applied to the risks of both total cancer incidence
(P¼0.018) and mortality (Po0.001).
The HRs for cancer in men were also separately determined for
alcohol-related and other cancers (Table 3). As expected, increased
risks were more evident for alcohol-related cancers than those for
other cancers. In a further analysis restricted to alcohol-related
cancers by smoking status, increased risks for the high-alcohol
categories were also observed among never smokers, though less
than among current smokers.
DISCUSSION
In this cohort study, the lowest risk of cancer was observed among
male occasional drinkers, and a linear positive association with
increasing ethanol intake was seen, with up to a 61% excess cancer
risk among subjects with an ethanol intake of X450g. The positive
association was similar for both the cancer incidence and
mortality, but was more striking among current smokers and for
alcohol-related cancers. Considerable interaction between smoking
and alcohol drinking was observed. On the other hand, no clear
association between alcohol drinking and cancer was found in
women, probably because few of them were regular drinkers.
Among males, nearly 13% of the cancers were considered
attributable to heavy drinking (X300g of ethanol per week).
We assigned occasional drinkers to the reference category since
nondrinkers were a mixture of never- and ex-drinkers, both of
which contained subjects who are unable to drink due to a
deficiency in the key enzyme for alcohol metabolism, common in
the Japanese population. This might have complicated the inter-
pretation of the results for nondrinkers. We were unable to assess
the risk of never- and ex-drinkers separately, since the baseline
questionnaire for cohort I did not discriminate abstainers from
nondrinkers. Additional analyses using cohort II subjects, however,
found that only 2% of all male subjects were ex-drinkers, and also
no marked difference in the association among nondrinkers
whether ex-drinkers were included or excluded. If this was also
the case in cohort I, it seems unlikely that ‘never-drinking’ would be
associated with an increased risk of cancer, though the possible
residual confounding effects cannot be ruled out. Approximately
half of the Japanese individuals were found to have a deficient
phenotype for aldehyde dehydrogenase-2, a key enzyme in the
conversion of acetaldehyde to acetate (Agarwal et al, 1981; Shibuya
and Yoshida, 1988), resulting in higher levels of acetaldehyde
exposure, which is considered to be carcinogenic (IARC, 1988). The
fraction of cancer risk attributable to alcohol might therefore be
greater among Japanese than among Western drinkers.
Previous studies have indicated that the effect of alcohol
drinking does not appear to be due to any specific type of
alcoholic beverage, but rather due to ethanol itself. In our study,
most male regular drinkers drank two or more types of alcohol;
36% of the total ethanol intake among these subjects was from
Japanese sake (rice wine), 33% from Japanese hard liquor, 24%
from beer and 7% from whisky, whereas o1% was from wine and
other alcoholic beverages.
Our results indicate that the combination of alcohol drinking
and smoking is associated with a particularly increased risk of
cancer and presumably makes a major contribution to both
incidence and mortality of the overall cancer risk, while no such
tendency was detected among never-smokers. Except for our
previous work, studies of the effect of interaction between drinking
and smoking on the total cancer risk in the Japanese are sparse
(Tsugane et al, 1999; Hara et al, 2002). CYP2E1, the expression of
which is induced by alcohol, metabolises procarcinogens, such as
N-nitroso compounds, present in tobacco smoke and foods
(Anderson et al, 1994); it also catalyses the conversion of alcohol
to acetaldehyde. Animal experiments have suggested that carcino-
gens in tobacco smoke are metabolised more slowly among
drinkers (Van de Wiel et al, 1993; Anderson et al, 1994). Although
interaction between alcohol and smoking may greatly contribute to
the risk of both cancer incidence and mortality, alcohol may also
be an independent risk factor, at least for alcohol-related cancers.
The major strengths of our study were its prospective design, its
high response rate, and the negligible proportion of losses to
follow-up. The collection of alcohol details before cancer diagnosis
precluded the exposure recall bias inherent in case–control
studies. However, misclassification of the self-reported alcohol
due to modified alcohol-drinking behaviour during the study
period is possible. However, these would probably be nondiffer-
ential and may underestimate the true relative risk. Although the
quality of the cancer registry system was satisfactory during the
study period, there was some geographical variation by study area,
so this was adjusted for in the analysis. We also confirmed that the
quality of the registry was not affected by drinking status at
baseline, so underreporting of cancer should also have been
nondifferential.
Our cohort study found that an increased ethanol intake
substantially elevates the risk of total cancer, but this effect
appeared to be largely due to interactions with smoking. For
cancer prevention therefore, combined cessation of smoking and
alcohol drinking is important for the reduction of cancer risk.
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